Logo image of 33L.DE

LULULEMON ATHLETICA INC (33L.DE) Stock Fundamental Analysis

FRA:33L - Deutsche Boerse Ag - US5500211090 - Common Stock - Currency: EUR

276.65  -5.8 (-2.05%)

Fundamental Rating

7

33L gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 42 industry peers in the Textiles, Apparel & Luxury Goods industry. 33L scores excellent points on both the profitability and health parts. This is a solid base for a good stock. 33L shows excellent growth, but is valued quite expensive already. This makes 33L very considerable for growth and quality investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year 33L was profitable.
33L had a positive operating cash flow in the past year.
Each year in the past 5 years 33L has been profitable.
In the past 5 years 33L always reported a positive cash flow from operatings.
33L.DE Yearly Net Income VS EBIT VS OCF VS FCF33L.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

1.2 Ratios

With an excellent Return On Assets value of 23.87%, 33L belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Looking at the Return On Equity, with a value of 41.97%, 33L belongs to the top of the industry, outperforming 92.86% of the companies in the same industry.
33L has a Return On Invested Capital of 30.81%. This is amongst the best in the industry. 33L outperforms 100.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for 33L is significantly above the industry average of 10.55%.
The 3 year average ROIC (29.73%) for 33L is below the current ROIC(30.81%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 23.87%
ROE 41.97%
ROIC 30.81%
ROA(3y)20.32%
ROA(5y)18.95%
ROE(3y)35.25%
ROE(5y)32.87%
ROIC(3y)29.73%
ROIC(5y)26.99%
33L.DE Yearly ROA, ROE, ROIC33L.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

1.3 Margins

33L has a better Profit Margin (17.14%) than 88.10% of its industry peers.
In the last couple of years the Profit Margin of 33L has remained more or less at the same level.
33L has a better Operating Margin (23.67%) than 88.10% of its industry peers.
33L's Operating Margin has been stable in the last couple of years.
The Gross Margin of 33L (59.22%) is comparable to the rest of the industry.
33L's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 23.67%
PM (TTM) 17.14%
GM 59.22%
OM growth 3Y2.55%
OM growth 5Y1.15%
PM growth 3Y3.21%
PM growth 5Y1.1%
GM growth 3Y0.89%
GM growth 5Y1.17%
33L.DE Yearly Profit, Operating, Gross Margins33L.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

9

2. Health

2.1 Basic Checks

33L has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for 33L remains at a similar level compared to 1 year ago.
33L has less shares outstanding than it did 5 years ago.
There is no outstanding debt for 33L. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
33L.DE Yearly Shares Outstanding33L.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M
33L.DE Yearly Total Debt VS Total Assets33L.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

33L has an Altman-Z score of 10.58. This indicates that 33L is financially healthy and has little risk of bankruptcy at the moment.
33L has a better Altman-Z score (10.58) than 95.24% of its industry peers.
There is no outstanding debt for 33L. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 10.58
ROIC/WACC3.47
WACC8.88%
33L.DE Yearly LT Debt VS Equity VS FCF33L.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.3 Liquidity

A Current Ratio of 2.16 indicates that 33L has no problem at all paying its short term obligations.
With an excellent Current ratio value of 2.16, 33L belongs to the best of the industry, outperforming 80.95% of the companies in the same industry.
A Quick Ratio of 1.38 indicates that 33L should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.38, 33L is in the better half of the industry, outperforming 78.57% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.16
Quick Ratio 1.38
33L.DE Yearly Current Assets VS Current Liabilites33L.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 15.02% over the past year.
The Earnings Per Share has been growing by 24.37% on average over the past years. This is a very strong growth
33L shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.07%.
Measured over the past years, 33L shows a very strong growth in Revenue. The Revenue has been growing by 21.62% on average per year.
EPS 1Y (TTM)15.02%
EPS 3Y23.52%
EPS 5Y24.37%
EPS Q2Q%16.07%
Revenue 1Y (TTM)10.07%
Revenue growth 3Y19.17%
Revenue growth 5Y21.62%
Sales Q2Q%12.68%

3.2 Future

33L is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.54% yearly.
The Revenue is expected to grow by 8.14% on average over the next years. This is quite good.
EPS Next Y2.6%
EPS Next 2Y5.54%
EPS Next 3Y6.31%
EPS Next 5Y11.54%
Revenue Next Year6.1%
Revenue Next 2Y6.7%
Revenue Next 3Y6.67%
Revenue Next 5Y8.14%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
33L.DE Yearly Revenue VS Estimates33L.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B 20B
33L.DE Yearly EPS VS Estimates33L.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10 20 30

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 21.23, the valuation of 33L can be described as rather expensive.
33L's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of 33L to the average of the S&P500 Index (26.25), we can say 33L is valued inline with the index average.
The Price/Forward Earnings ratio is 20.69, which indicates a rather expensive current valuation of 33L.
33L's Price/Forward Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.15, 33L is valued at the same level.
Industry RankSector Rank
PE 21.23
Fwd PE 20.69
33L.DE Price Earnings VS Forward Price Earnings33L.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, 33L is valued a bit more expensive than the industry average as 64.29% of the companies are valued more cheaply.
Based on the Price/Free Cash Flow ratio, 33L is valued a bit more expensive than the industry average as 73.81% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 23.68
EV/EBITDA 12.29
33L.DE Per share data33L.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 33L does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of 33L may justify a higher PE ratio.
PEG (NY)8.16
PEG (5Y)0.87
EPS Next 2Y5.54%
EPS Next 3Y6.31%

0

5. Dividend

5.1 Amount

No dividends for 33L!.
Industry RankSector Rank
Dividend Yield N/A

LULULEMON ATHLETICA INC

FRA:33L (5/30/2025, 7:00:00 PM)

276.65

-5.8 (-2.05%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)03-27 2025-03-27/amc
Earnings (Next)06-03 2025-06-03/amc
Inst Owners92.02%
Inst Owner ChangeN/A
Ins Owners0.27%
Ins Owner ChangeN/A
Market Cap33.24B
Analysts74.63
Price Target301.05 (8.82%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.81%
Min EPS beat(2)2.91%
Max EPS beat(2)4.71%
EPS beat(4)4
Avg EPS beat(4)4.38%
Min EPS beat(4)2.91%
Max EPS beat(4)5.41%
EPS beat(8)8
Avg EPS beat(8)5.78%
EPS beat(12)11
Avg EPS beat(12)5.32%
EPS beat(16)15
Avg EPS beat(16)8.62%
Revenue beat(2)0
Avg Revenue beat(2)-0.59%
Min Revenue beat(2)-0.92%
Max Revenue beat(2)-0.26%
Revenue beat(4)0
Avg Revenue beat(4)-1.49%
Min Revenue beat(4)-3.46%
Max Revenue beat(4)-0.26%
Revenue beat(8)1
Avg Revenue beat(8)-0.9%
Revenue beat(12)5
Avg Revenue beat(12)0.03%
Revenue beat(16)7
Avg Revenue beat(16)0.61%
PT rev (1m)-14.33%
PT rev (3m)-19.82%
EPS NQ rev (1m)-0.05%
EPS NQ rev (3m)-5.73%
EPS NY rev (1m)-0.49%
EPS NY rev (3m)-3.37%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.27%
Revenue NY rev (1m)-0.16%
Revenue NY rev (3m)-0.76%
Valuation
Industry RankSector Rank
PE 21.23
Fwd PE 20.69
P/S 3.54
P/FCF 23.68
P/OCF 16.5
P/B 8.67
P/tB 9.03
EV/EBITDA 12.29
EPS(TTM)13.03
EY4.71%
EPS(NY)13.37
Fwd EY4.83%
FCF(TTM)11.68
FCFY4.22%
OCF(TTM)16.77
OCFY6.06%
SpS78.12
BVpS31.9
TBVpS30.64
PEG (NY)8.16
PEG (5Y)0.87
Profitability
Industry RankSector Rank
ROA 23.87%
ROE 41.97%
ROCE 43.49%
ROIC 30.81%
ROICexc 46.99%
ROICexgc 49.22%
OM 23.67%
PM (TTM) 17.14%
GM 59.22%
FCFM 14.96%
ROA(3y)20.32%
ROA(5y)18.95%
ROE(3y)35.25%
ROE(5y)32.87%
ROIC(3y)29.73%
ROIC(5y)26.99%
ROICexc(3y)45.65%
ROICexc(5y)41.54%
ROICexgc(3y)46.74%
ROICexgc(5y)45.9%
ROCE(3y)41.97%
ROCE(5y)38.1%
ROICexcg growth 3Y-2.73%
ROICexcg growth 5Y3.8%
ROICexc growth 3Y3.22%
ROICexc growth 5Y3.16%
OM growth 3Y2.55%
OM growth 5Y1.15%
PM growth 3Y3.21%
PM growth 5Y1.1%
GM growth 3Y0.89%
GM growth 5Y1.17%
F-Score8
Asset Turnover1.39
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 154.35%
Cap/Sales 6.51%
Interest Coverage 5244.14
Cash Conversion 76.96%
Profit Quality 87.26%
Current Ratio 2.16
Quick Ratio 1.38
Altman-Z 10.58
F-Score8
WACC8.88%
ROIC/WACC3.47
Cap/Depr(3y)181.68%
Cap/Depr(5y)168.92%
Cap/Sales(3y)7.05%
Cap/Sales(5y)6.53%
Profit Quality(3y)77.23%
Profit Quality(5y)86.23%
High Growth Momentum
Growth
EPS 1Y (TTM)15.02%
EPS 3Y23.52%
EPS 5Y24.37%
EPS Q2Q%16.07%
EPS Next Y2.6%
EPS Next 2Y5.54%
EPS Next 3Y6.31%
EPS Next 5Y11.54%
Revenue 1Y (TTM)10.07%
Revenue growth 3Y19.17%
Revenue growth 5Y21.62%
Sales Q2Q%12.68%
Revenue Next Year6.1%
Revenue Next 2Y6.7%
Revenue Next 3Y6.67%
Revenue Next 5Y8.14%
EBIT growth 1Y13.57%
EBIT growth 3Y22.21%
EBIT growth 5Y23.02%
EBIT Next Year21.76%
EBIT Next 3Y11.5%
EBIT Next 5Y11.1%
FCF growth 1Y-3.7%
FCF growth 3Y16.77%
FCF growth 5Y32.6%
OCF growth 1Y-1.02%
OCF growth 3Y17.83%
OCF growth 5Y27.7%